RUNX1 and acute promyelocytic leukemia: Several studies have reported that acute promyelocytic leukemia (APL) has a molecular “signature” associated with the presence of the PML-RARα gene fusion, which is distinct from the signatures of AMLs expressing AML1-ETO, CBFβ-SMMHC or C/EBPα mutations.